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ABSTRACT 
A central question during development is how single cells form functional multi-cellular 
organ structures. The high reproducibility indicates intricate synchronization of cellular 
behaviors such as migration, proliferation and cell shape changes. How mechanical signals or 
forces regulate cell shape changes is less studied, however several reports indicate a role of 
mechanical forces in malignancy Increased force or stiffness in the matrix cause loss of tissue 
architecture associated with tumor progression. Important hallmarks of advanced cancerous 
tumors are the loss of epithelial character from the original tissue and the appearance of more 
mesenchymal-like cells, especially at the periphery, where the tumor cells are in contact with 
surrounding stromal cells. Typical of this epithelial–mesenchymal transition (EMT) is the 
loss of cell–cell adhesion and apical–basal cell polarity as well as the increased motility of 
tumor cells. Although the importance of EMT for tumor progression is widely accepted much 
less is known about the relationship between cell polarity and early events in carcinogenesis. 
The aim of this thesis was to study the role of AmotL2 during blood vessel formation and 
tumor progression. 
In this thesis it is demonstrated that angiomotin-like 2 is expressed as two isoforms with 
distinct functions. The longer isoform p100 AmotL2 is localized to cell-cell junctions, and 
associates to the VE-cadherin complex where it couples adherent junctions to contractile 
actin fibers. Using gene inactivation strategies in zebrafish, mouse and endothelial cell 
culture systems, we show that inactivation of p100 AmotL2 dissociates VE-cadherin from 
cytoskeletal tensile forces that affect endothelial cell shape. We report that AmotL2 is 
essential for vascular lumen expansion, by transmission of junctional force between cells. We 
propose a novel mechanism for which transmission of mechanical force is essential for the 
coordination of cellular morphogenesis. 
This thesis also provides data regarding p60 AmotL2, the shorter isoform. We show that 
hypoxic stress activates c-Fos dependent transcription of p60 AmotL2 resulting in disruption 
of apical basal polarity. Activation of p60 AmotL2 results in formation or of large 
intracellular vesicles that sequester Crb3 and Par3 polarity complexes inside the cell. In 
human tumors from breast and colon cancer patient’s p60 AmotL2 expression correlates with 
loss of tissue architecture and cell polarity. Furthermore we provide data showing that p60 
AmotL2 acts as a p100 AmotL2 antagonist sequestering p100 into intracellular vesicles. This 
results in alterations in actin reorganization and weakened cell-cell adhesions. These data 
point to a novel pathway, which controls metastatic spread. 
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1   INTRODUCTION 
1.1    FOREWORD 
The appearance of cells and the ability to change structure and shape has been well studied 
and documented during the 20th century. As far back as 1917, D’Arcy Thompson published a 
paper ‘On growth and form’ in an attempt to explain cell shape changes during 
morphogenesis by using simple mathematical and physical formulations.  
In this thesis I will touch upon mechanisms that is needed to establish and maintain cellular 
architecture, but also how these traits are then deregulated during malignant transformation. I 
believe that in order to be able to understand a disease, one must first understand how cells 
interact under normal conditions. The getting in and out of shape concept reflects on cells 
ability to change structure and shape when it comes to for example forming a tube or an 
organ, and how this organized structure is lost during tumor progression. Important hallmarks 
of advanced tumors are the loss of structure and character from the original tissue, and the 
appearance of more mesenchymal-like structure.  
 
2   TISSUE DEVELOPMENT AND HOMEOSTASIS  
Cells are the building blocks of multicellular organisms. Cells make tissues and tissues make 
organs, which provide functionality to the living creature. The more complex the organism 
the more organized and specialized are the cells.  
There are many different types of cells, but all have the same basic structure. All cells consist 
of a cell membrane that envelops the cell, regulating what moves in and out. Cells also have 
a cytoskeleton that organizes and maintains shape. All cells contain two different kinds of 
genetic material, DNA and RNA. Organelles analogous to the organs of the human body are 
also present in cells. The organelles in the eukaryotic cells consist of a nucleus, where all the 
genetic material is stored, mitochondria which generates the cells energy, endoplasmatic 
reticulum that with the Golgi apparatus forms the cell packing system, centrosome the 
cytoskeleton organizer and lysosomes that contain digestive enzymes that breaks down 
excessive or worn out organelles.   
During embryogenesis, the inner cell mass of the egg consist of a single layer of cells that 
migrate through the primitive streak turning single layer, into two and later into three layers 
of cells. These layers are called the germ layers and give rise to all the tissues in the body. 
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Each layer forms specific tissues and organs in the embryo. The outermost layer, the 
ectoderm differentiates to form the nervous system. The middle layer, the mesoderm forms 
connective tissue and muscle tissue in the body. And the inner layer, the endoderm gives rise 
to epithelium of the digestive system and the respiratory system. 
For cells to be able to organize into tissues various biological processes are essential. Cells 
must be able to sense their environment, including where they are in relation to their 
neighbours. This is mediated by direct interaction of cells with the ECM through various 
receptors, such as integrins (Yu, Datta et al. 2005). Cells will also sense and alter the 
assembly, stiffness and composition of the ECM (Kass, Erler et al. 2007).  Communication 
with other cells through the adhesion molecules, such as the cadherins (Gumbiner 2005), 
these cues provide instructions that enable cells to begin to assemble into groups. In a 
forming tissue, cells must coordinate asymmetrical distribution of polarity proteins (Wang 
and Nathans 2007). As a consequence the cytoskeleton and the cell trafficking machinery 
organize asymmetrically (Goldstein and Macara 2007). 
 
 
Figure 1. Example of Thompsonian transformation grids. Here illustrating transformation of 
Argyropelecus olfersi into Sternoptyx diaphana by applying a 20° shear mapping. Figure taken from 
Wikipedia.com 
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2.1   CELL POLARITY 
Cell polarity is a fundamental feature that describes the ability of the cell to create order and 
organization. The organization seen at a macro-molecular level (organs, tubes and sheets of 
cells) is a reflection of organization observed at a micro-molecular level (the individual 
building blocks of the cell). 
Almost every eukaryotic cell is asymmetric or polarized. For individual cells to form a 
tissue, polarity must be arranged in space and time (O'Brien, Zegers et al. 2002).  Biological 
processes such as cell division, cell death, shape changes, cell migration and differentiation, 
must be coordinated with the polarity requirements of a tissue to form an organ (Nelson 
2003).  
There are different types of polarity (figure. 2) that are thought to regulate morphogenesis 
of epithelial structures: planar cell polarity which is the polarization of a field of cells 
within the plane of the same sheet, front-rear polarity used by migrating cells to maintain 
directionality, mitotic-spindle polarity used for positioning of daughter cells during cell 
division and apical-basal polarity which is the asymmetrical distributions of proteins and 
organelles along the apical-basal axis. 
In this thesis I focus on Apical-basal polarity due to its prominent role in the acquisition of 
cell shape and directional transport. 
The establishment of apical –basal polarity allows for changes in cellular structure and 
positioning of cell organelles in order to maintain asymmetry. The existence of non-
coalescent apical and basolateral plasma membrane domains, which have a differential 
composition of proteins and lipids, is a feature of polarization allowing for directional 
transport of molecules across the epithelial sheet. Differences in membrane composition 
was shown back in 1982 when MDCK cells infected with viruses budding from either the 
apical or basolateral membrane had unique phospholipid compositions (van Meer and 
Simons 1982). In epithelial structures, such as the intestinal lining the apical membrane 
faces the luminal space and is distinguished by the presence of microvillus. The basal 
compartment is attached to the basement membrane. The asymmetric composed 
membranes has a polarized trafficking machinery that is composed of secretory organelles 
(the endoplasmic reticulum (ER) and Golgi complex) and endosomal compartments that are 
required for the generation and maintenance of the asymmetric distribution of plasma 
membrane proteins. Another feature of polarization is the correct positioning of the cell 
nucleus resulting in asymmetric cell division. 
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Figure 2.  Different types of polarity that regulates morphogenesis. Adapted from Muthuswamy et al 
2012, Annu. Rev.Cell. Dev Biol. 
 
The general steps of cell polarity including its establishment and maintenance are highly 
conserved from Drosophila to humans. Mechanisms that promote the establishment of 
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apical-basal polarity vary between different model organisms and mammalian epithelial 
cells. However in epithelia, the formation of polarized cell layers depends on cell adhesion 
complexes and polarity protein complexes. The adherent and tight junctions contribute to 
the formation and maintenance of the apical and basolateral domains mainly through two 
adhesive complexes: cadherin–catenin and nectin–afadin (Niessen and Gottardi 2008). 
Studies conducted in late 1980’s showed that the apical pole is independent of junction 
formation while formation of a basolateral membrane requires cell-cell interactions (Vega-
Salas, Salas et al. 1987). The ECM, in particular the basement membrane also plays an 
important role in orienting apical-basal polarity. More specifically, the integrins have been 
recognized as essential mediators of apical-basal polarity. Genetic deletions of the β1 
integrins have revealed that they have a central role in establishing cell polarity (Lee and 
Streuli 2014). 
The polarity proteins that regulate apical-basal polarity are grouped into protein complexes 
according to their known localization: the subapically localized PAR 
(Cdc42/Par3/Par6/aPKC) and Crumbs (Crb/Pals1/PATJ) complexes and the basolaterally 
localized Scribble complex (Scrib/Lgl/Dlg) (Bryant and Mostov 2008). During the 
establishment and maintenance of cell polarity, the polarity complexes interact with each 
other. For example Scribble restricts the activity of the Crumbs complex to the apical 
domain (Bilder and Perrimon 2000) and thus the polarity complexes antagonize each other.  
To gain further insight into how apical-basal polarity is regulated a short summary of the 
protein complexes involved follows. 
 
2.1.1   PAR Complex 
The PAR (partitioning defective) genes was first identified as proteins needed for 
asymmetric division during early embryogenesis in C.elegans as mutations in the PAR 
genes lead to defects in cell cleavage (Kemphues, Priess et al. 1988). In mammalian 
epithelium PARD3, PARD6 and atypical protein kinase C (aPKC) form a Par complex that 
localizes to apical tight junctions and regulates apical junction formation (Hirose, Izumi et 
al. 2002). PARD6 binds to aPKC through its PB1 domain and functions as an inhibitor of 
aPKC kinase activity and as a targeting subunit to recruit aPKC substrates, including 
PARD3 (Hirano, Yoshinaga et al. 2005).  
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Upon phosphorylation, PARD3 is lost from the apical membrane and localizes to adherent 
junctions in which it functions independently from PARD6 and aPKC (Morais-de-Sa, 
Mirouse et al. 2010). The Par complex proteins have also been shown to be deregulated 
during transformation. PARD6 is amplified and overexpressed in breast cancer (Nolan, 
Aranda et al. 2008). In contrast loss of Par3 has been reported to promote breast 
tumorigenesis and metastasis (McCaffrey, Montalbano et al. 2012; Xue, Krishnamurthy et 
al. 2013). 
 
2.1.2   Crumbs Complex 
Another complex located at the apical membrane is the Crumbs complex. Crumbs is a 
transmembrane protein, Crumbs (isoforms CRB1-3) is associated with Pals1 (MPP5), and 
PATJ (INADL) scaffold proteins.  During polarization, the Crumbs complex establishes 
apical identity by recruiting actin cytoskeletal regulators such as moesin and βH-spectrin 
(Medina, Williams et al. 2002).  In Drosophila embryos, crumbs mutation fail to assemble 
or stabilize junctions, which leads to breakdown of epithelial structure and extensive cell 
death (Tepass, Theres et al. 1990). Down-regulation of CRB3 in immortal embryonic 
mouse kidney cells promote tumor progression and metastasis (Karp, Tan et al. 2008).  
 
2.1.3  Scribble complex 
The Scribble complex is localized at the basolateral domain and is required for restricting 
the apical domain by antagonizing the Par complex (St Johnston and Sanson 2011). 
Scribble complex consists of three members, Scribble (SCRIB), Discs large (isoforms, Dlg 
1-5) and Lethal giant larvae (isoforms, LLGL1-2). Scribble associates indirectly with Dlg 
via a linker protein, guanylate kinase (GUK), but binds directly to LLGL2 through its LRR 
(leucine-rich repeat) domain. In Drosophila mutations of Scrib cause defects in epithelial 
organization that results in embryonic lethality (Bilder and Perrimon 2000). It has also been 
proposed that Scrib could act as a tumor suppressor by regulating epithelial cell adhesion 
and migration as Scrib depletion disrupts E-cadherin mediated cell-cell adhesion (Qin, 
Capaldo et al. 2005). 
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2.2   CELL-CELL JUNCTIONS 
Cell junctions are multi-protein complexes that connect neighbouring cells. They allow for 
the preservation and proper functioning of epithelial sheets. These junctions are also 
important in organization of tissues where cells can only adhere to other cells from the 
same tissue. Cell junctions are divided into four groups: tight junctions (TJ), adherent 
junctions (AJ), desmosomes and gap junctions. 
 
2.2.1   Adherent Junctions 
Adherent junctions (AJ) serve as points of cell-cell attachment that also anchor the actin 
cortex to the apical circumference of the cell, allowing contractile forces to be transmitted 
between cells (Niessen, Leckband et al. 2011). AJ’s in epithelial cells contain the 
homophilic cell adhesion molecule E-cadherin whereas endothelial cells express VE-
cadherin. E-cadherin is an epithelium-specific cadherin that is required for the development 
and maintenance of the normal function of all epithelial cells in tissues. The loss or down-
regulation of E-cadherin is a key event in the process of tumor invasion and metastasis (the 
deregulation of E-cadherin and its consequence is further discussed in paragraph 3.3).  
VE-cadherin is an endothelium-specific cadherin, which plays a relevant role in vascular 
homeostasis. It has been demonstrated that VE-cadherin is required for normal 
vasculogenesis, angiogenesis, and for the maintenance of vascular integrity (Dejana, 
Orsenigo et al. 2008). Loss of VE-cadherin results in apical-basal polarity and cytoskeletal 
defects (Carmeliet, Lampugnani et al. 1999; Strilic, Kucera et al. 2009; Harris and Nelson 
2010). 
The extracellular domain of VE/E-cadherin mediates homotypic interactions with 
molecules on neighbouring cells whereas its intracellular tail interacts with the actin 
cytoskeleton through binding β-catenin and α-catenin. Because α-catenin binds actin 
filaments, the VE/E-cadherin–β-catenin–α-catenin complex is thought to link adherens 
junctions to the actin cortex. Although biochemical studies suggest that mammalian α-
catenin cannot bind β-catenin and F-actin at the same time (Drees, Pokutta et al. 2005; 
Yamada, Pokutta et al. 2005). The E-cadherin complex might be linked to F-actin via 
additional proteins, such as EPLIN (Abe and Takeichi 2008) or vinculin (Yonemura, Wada 
et al. 2010). 
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2.3   INTEGRINS AND THE EXTRACELLULAR MATRIX 
The extracellular matrix (ECM) consists of tissue-specific proteins such as collagen, 
laminin and fibronectin and non-matrix proteins such as phosphatases, kinases and growth 
factors (Naba, Hoersch et al. 2012). Adhesion complexes at the cell surface physically link 
the ECM to the cytoskeleton. For example, focal adhesions (FAK), comprised of integrins, 
talin, vinculin and other proteins, connect the ECM to actin filaments (Brakebusch and 
Fassler 2003). Besides physically connecting cells within tissues, ECM’s act as elastic 
scaffolds that resist cell-traction forces and thereby regulate tissue development by 
modifying physical force distributions, changing the cellular force balance, and altering cell 
shape (Huang and Ingber 1999; Beloussov, Louchinskaia et al. 2000).  Changes in cell 
shape can alter diverse biological functions including: cell migration, growth, apoptosis, 
differentiation, contractility and cellular self-assembly (Chen, Mrksich et al. 1997; Engler, 
Sen et al. 2006; Alcaraz, Xu et al. 2008; Guo, Ouyang et al. 2012). 
Epithelial branching morphogenesis is an example in which ECM remodeling play a central 
role in regulating final tissue form, as well as in amplifying the total tissue surface area 
available for molecular exchange in organs, such as lung, kidney, pancreas and mammary 
gland. These epithelial tissues exhibit 3D treelike structures that are built through budding 
and branching, which are controlled through mechanical interplay between cells and their 
ECM scaffolds. For example, during the formation of epithelial branching patterns in the 
embryonic mouse lung, a mechanical balance between cell-generated traction forces and 
differences in the ability of the underlying ECM to resist these stresses in different regions 
of the growing organ has been observed. Budding and cell proliferation are enhanced in 
regions of ECM thinning that exhibit increased flexibility, whereas growth is suppressed in 
regions that exhibit a thicker and more rigid basement membrane (Moore, Polte et al. 
2005). 
Cells can through their integrins sense the rigidity of the ECM, and adjust their tension 
accordingly (Saez, Buguin et al. 2005). When cells attach to stiff matrices they form large 
clusters of focal adhesions, binding more stress fibers leading to higher tension. As a 
consequence cell-cell adhesions weakens, resulting in disruption of the actin adhesion belt 
(Tsai and Kam 2009; DuFort, Paszek et al. 2011). However when cells are attached to 
softer matrices, integrin clusters are fewer. Also the binding of integrins to stress fibers is 
less, resulting in lower tension and stable adherent junctions (DuFort, Paszek et al. 2011).  
The cadherins located at the cell adhesion sites have mechanosensing properties. VE/E 
cadherin can through their binding to actin transmit force.  
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2.4  CELL SHAPE 
The paragraphs thus far have described features essential for tissue morphogenesis and 
regulation of cell shape and size. Another important feature is the contractile actin 
cytoskeleton. The following paragraphs will give a general overview of the cytoskeleton, 
but will mostly focus on the actin cytoskeleton since it is believed to be the main mediator 
of mechanical force during morphogenesis and homeostasis.  
 
2.5   THE CYTOSKELETON 
The cytoskeleton is the framework of intra-cellular filaments that provide support for 
cellular shape, motility and contraction. Eukaryotic cells contain three main cytoskeletal 
filaments: microfilaments (actin filaments), intermediate filaments and microtubules. 
Microtubules are considered to be the largest type of filament, with a diameter of about 25 
nanometers (nm), and they are composed of a protein called tubulin (Fletcher and Mullins 
2010). Actin filaments are the smallest type, with a diameter of about 6 nm, they are made 
of a protein called actin. Intermediate filaments, as their name suggests, are mid-sized, with 
a diameter of about 10 nm (Munjal and Lecuit 2014). Unlike actin filaments and 
microtubules, intermediate filaments are constructed from a number of different subunit 
proteins. The intermediate filaments are in general polymers that are subdivided into six 
types depending on the protein structure. Keratins, lamins, desmin and vimentin are all part 
of the intermediate filaments (Fletcher and Mullins 2010). 
 
2.5.1  Actin Cytoskeleton 
The actin filaments are grouped into higher-order structures, forming bundles or three-
dimensional networks with the traits of semisolid gels. Actin-binding proteins, which are 
critical components of the actin cytoskeleton, are crucial for the assembly and disassembly 
of actin filaments, they’re cross-linking into bundles and networks, and their association 
with other cell structures.  
Actin molecules are proteins of 375 amino acids. Binding sites present at each actin 
monomer (globular G actin) allows for head-to-tail interactions with other actin monomers 
to form filaments of actin (filamentous F actin) (Giganti, Plastino et al. 2005; Winder and 
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Ayscough 2005). Each monomer is rotated by 166 degrees in the filaments, which therefore 
have the appearance of a double-stranded helix. All the actin monomers are oriented in the 
same direction allowing the actin filaments to have a distinct polarity, and their ends (plus 
and minus ends) are distinguishable from one another.  
Contractile microfilaments, composed of aligned bundles of actin and myosin II filaments, 
form a contractile cytoskeletal network that spans from the nucleus to the cell cortex, where 
it links to the cytoplasmic face of transmembrane integrin receptors and cadherins on the 
plasma membrane (Verkhovsky, Svitkina et al. 1995; Verkhovsky, Svitkina et al. 1997; 
Backouche, Haviv et al. 2006). These traction forces lead to patterns of mechanical 
contraction, which coordinates various transformations in cell and tissue shape. In 
developing epithelium, the mechanical linkage between the cytoskeletons of neighbouring 
cells occurs primarily at the apical adherent junctions (Gates and Peifer 2005; Halbleib and 
Nelson 2006), in which the intracellular domains of transmembrane cadherin proteins form 
an anchoring complex with β-catenin and its actin-binding partner, α-catenin (Ozawa and 
Kemler 1992). Although the nature of the connection between E-cadherin and the actin 
cytoskeleton remains unclear (Drees, Pokutta et al. 2005), genetic studies suggests that 
catenins mediate the mechanical linkage between neighbouring cells (Gates and Peifer 
2005; Cavey, Rauzi et al. 2008).  
Coupling of cell-generated mechanical forces through cell-cell adhesions results in an 
apical constriction of epithelial cells, which reduces the size of the apical surface of each 
cell relative to its base (Sawyer, Harrell et al. 2010). This physical constriction is used to 
deform the cells and thereby generate a variety of epithelial patterns during morphogenesis 
including folding, pitting, and tubing (Colas and Schoenwolf 2001; Leptin 2005). 
 
2.6   VESICULAR TRAFFICKING 
Molecules and most proteins are often too large to pass directly through membranes. Large 
molecules are instead packed into small membrane-wrapped containers called vesicles. 
Vesicles are constantly forming at the plasma membrane, the endoplasmatic reticulum 
(ER), and the Golgi. When formed, vesicles deliver their contents to destinations within or 
outside the cell.  
mRNA is translated into protein at the ribosomes. Proteins that will be secreted contain a 
signal sequence that directs ribosomes to bind to the ER, the growing protein chain passes 
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into the lumen of the ER. As they move through the ER, proteins are subjected to post-
translational modifications including refolding, disulfide bond formation and glycosylation. 
The proteins are pinched off in the ER membrane and transported through COP II vesicles 
to the Golgi. In the Golgi apparatus proteins undergo further modifications including 
glycosylation, phosphorylation and sulfation. At the outer layer of the Golgi, proteins are 
sorted into COPI vesicles for transport to specific destinations.  
Vesicles are transported along microtubules to the cell membrane, releasing their contents 
in the process of exocytosis. However proteins can also be engulfed by the cell through the 
endocytic pathway, often large proteins that cannot pass through the cell membrane are 
transported through the endocytic pathway. The endocytic pathway can be divided into four 
categories: clathrin mediated endocytosis, caveolae, macropinocytosis and phagocytosis. 
Vesicular trafficking has also been shown to be crucial for maintenance and assembly of 
cell polarity (Qi, Kaneda et al. 2011). The vesicular trafficking system helps sorting of 
apical and basolateral proteins through the production and fission of different types of post 
Golgi carrier vesicles. Vesicular fission seems to be mediated through dynamin 2, in apical 
routes (Salvarezza, Deborde et al. 2009), and PKD has a role in basolateral routes (Yeaman, 
Ayala et al. 2004). Myosin 2 and myosin 6 mediate basolateral transport from the TGN 
(Musch, Cohen et al. 1997; Au, Puri et al. 2007), whereas myosin 5 mediates apical 
transport (Roland, Bryant et al. 2011).   
 
2.6.1   The TRAPP complexes 
The TRAPP (Transport protein particle) complex was first characterized as a large protein 
complex functioning in the later stages of ER-to-Golgi traffic in yeast (Sacher, Jiang et al. 
1998; Sacher, Barrowman et al. 2001). TRAPP consists of two distinct complexes, TRAPP 
I is ∼300 kDa in size and contains seven subunits, whereas TRAPP II is ∼1000 kDa and 
contains an additional three subunits Trs65p, Trs120p and Trs130p (Sacher, Barrowman et 
al. 2001). The yeast subunits of TRAPP and their corresponding mammalian othologues 
can be found in table 1. 
 The different subunits share some sequence similarity, six of the smallest subunits are 
categorized into two families of three (Bet3p, Trs33p and Trs31p; and Bet5p, Trs20p and 
Trs23p) (Sacher, Barrowman et al. 2000). TRAPP I and II both co-function with an early 
Golgi marker and are present in the cytosolic pool. The association to the Golgi network is 
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stable, due to Bet3p does not relocate to the ER when ER-to-Golgi traffic is blocked, unlike 
components that cycle between the ER and Golgi, and the complex remains stable under 
these conditions (Barrowman, Sacher et al. 2000). 
 
Yeast TRAPP Mammalian orthologue 
Bet5p TRAPPC1 
Trs20p TRAPPC2 
Bet3p TRAPPC3 
Trs23p TRAPPC4 
Trs31p TRAPPC5 
Trs33p TRAPPC6a, b 
Trs65 None 
Trs85p None 
Trs120p TRAPPC9 
Trs130p TRAPPC10 
           Table 1. Complete list of TRAPP proteins and their mammalian orthologues. 
 
It has been suggested that the TRAPP complex acts as a GEF (Cai, Zhang et al. 2005; 
Liang, Morozova et al. 2007). Ypt/Rab GTPases are conserved key controllers of the 
different protein transport steps in all eukaryotic cells. They switch between the GTP-bound 
‘on’ and the GDP-bound ‘off’ states with the help of upstream regulators. Guanine 
nucleotide exchange factors (GEFs) activate GTPases by accelerating their intrinsic GDP 
release and GTP uptake reactions. While in the on state, Ypt/Rabs interact with several 
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effectors that supply the various substeps of vesicular transport, from vesicle formation 
through their motility, tethering and fusion.  
 
Figure 3. The TRAPP vesicular pathway in yeast. Figure adapted from Barrowman et al 2010, Nat Rev 
Mol Cell Biol. 
 
In yeast, mutations in the two essential TRAPP II-specific subunits, Trs120p and Trs130p, 
abolish the Ypt31/32p GEF activity of TRAPP while increasing the Ypt1p GEF activity 
(Morozova, Liang et al. 2006). Mutations in Trs130 blocks vesicle trafficking through or 
from the Golgi, however mutations in Trs120 results in membrane structures that resemble 
Berkley bodies (large vesicles) and disrupts trafficking of proteins that recycle through the 
early endosome (Cai, Zhang et al. 2005).  
The GEF activity of mammalian TRAPP has not been shown yet.  However the mammalian 
TRAPPII complex has been suggested to function as a tethering complex that binds to Golgi-
derived (COPI coated) vesicles to mediate Golgi traffic and has been implicated in the 
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selective transport of proteins to the plasma membrane in polarized cells (Qi, Kaneda et al. 
2011; Westlake, Baye et al. 2011). 
 
2.7   MESENCHYMAL TO EPITHELIAL TRANSITION 
Transitions between epithelial and motile mesenchymal states are important during 
embryogenesis and organogenesis. They allow cells to alter their morphology and to change 
interactions with neighbouring cells and the microenvironment. These processes include 
epithelial to mesenchymal transition (EMT) (which is discussed in segment 3.3) and 
mesenchymal to epithelial transition (MET). MET occurs during embryogenesis giving rise 
to the trophoectoderm generating the first embryonic epithelium (Larue and Bellacosa 2005). 
At the early stage, MET is thought to be regulated by EphA4 by modulating cell shape 
changes in preparation for epithelialization (Barrios, Poole et al. 2003).  
There is growing evidence supporting the fact that MET is crucial for later stages of cancer 
progression, metastasis. In colon carcinoma, recent reports show that the primary tumor and 
its corresponding liver metastasis have a mixed population of epithelial-mesenchymal 
phenotype whereas the center of the tumor retained epithelial characteristics. However, tumor 
cells located at the invasive front had acquired mesenchymal traits (Brabletz, Hlubek et al. 
2005). 
 
 
2.8  TUBULOGENESIS  
Tube formation is a common feature of many developing organs such as lung, kidneys, 
mammary glands as well as the blood circulatory network. The function of these tubular 
structures is to transport gases, liquids and waste products and thus plays an essential role in 
organ function. Although the morphology of tubes may differ between tissues they still have 
some features in common. For example, established cellular tubes form apical and basal 
membrane domains, inter-cellular junctions form a basal membrane. There are clearly 
molecular mechanisms in common in tube formation, as for example Par3 controls tube 
formation in the neuro-ectoderm of the zebrafish, vessel lumen formation in mice as well as 
epithelial lumen formation in human cells (Bryant and Mostov 2008). The loss of polarity is 
also important for the expansion and formation of new tubes. In the case of endothelial cells, 
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migrating cells form anterior posterior polarity in which the leading cell, the tip cell, form 
filopodia which guides the migration and consequent anastomosis of neighbouring 
capillaries. Loss of polarity is also of importance in the context of cancer. Cancers such as 
colorectal, breast and prostate form polarized glandular tubular structures in the benign state 
but loose polarity during invasion and metastasis. Knowledge regarding the process of tube 
formation may provide not only important clues on how organs are formed but also how a 
malignant phenotype develops.  
 
2.9    Blood vessel formation 
The vascular system in higher animals consists of a highly organized network of arteries and 
veins. The vascular system permits blood to circulate and transport nutrients, oxygen, carbon 
dioxide and hormones to and from the cells in the body helping to maintain homeostasis. The 
vascular system is divided into blood and the lymphatic network, both being lined by 
endothelial cells (EC’s). The arteries and the arterioles help transporting oxygenated blood 
from the heart to tissues in the body. The blood is then carried back through the veins and 
venules, being removed of waste products. Arteries and veins differ in the degree of blood 
pressure and the SMC’coating, but also their EC’s and SMC have distinct identity and origin 
(Carmeliet 2003). It has been hypothesized that differences in blood flow between the arteries 
and veins were assumed to be responsible for arterial-venous specification (Chung and 
Ferrara 2011). However studies in the zebrafish has demonstrated that Notch signaling 
restricts angioblasts to either arterial fate, by expression of Ephrin B2 or a venous fate marked 
by EphB4 (Zhong, Childs et al. 2001). 
The vascular system is crucial for development and is therefore also among the first to 
develop during embryogenesis (Chung, Lee et al. 2010; Chung and Ferrara 2011). Upon 
deregulation, the formation of blood vessels can contribute to malignant disorders such as 
retinopathy, cancer and rheumatoid arthritis. 
During embryonic development in vertebrates, individual angioblasts migrate to the 
embryonic midline and differentiate into EC.  These cells start to express typical EC markers 
such as PECAM-1 and VEGFR-2, which guides the cells to the midline.  Upon reaching the 
midline cells elongate to form parallel cords, followed by the formation of a central lumen 
allowing for the initiation of circulation (Strilic, Kucera et al. 2009; Zeeb, Strilic et al. 2010; 
Herbert and Stainier 2011; Xu and Cleaver 2011). 
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Blood vessel formation is divided into vasculogenesis and angiogenesis. Vasculogenesis is 
the formation of blood vessels from differentiating hemangioblasts (formation of blood 
vessels when no pre-existing ones). The term angiogenesis however is the formation of new 
blood vessels from pre-existing ones.  
 
2.9.1   Angiogenesis 
After the formation of a primitive vascular system through vasculogenesis the blood vessel 
network expand through the process of angiogenesis. This term reflects the formation of new 
vessels from pre-existing ones. Physiological angiogenesis occurs also in adults during 
wound healing, menstrual cycle, pregnancy and skeletal muscle growth. Pathological 
angiogenesis promotes diseases such as obesity, rheumatoid arthritis, cancer and psoriasis. 
Pathological and physiological angiogenesis are both initiated in response to low levels of 
oxygen and nutrients. The organization of the vasculature in a healthy organism is maintained 
by a balance between pro-angiogenic and anti-angiogenic factors (Reinacher-Schick, Pohl et 
al. 2008). This balance is lost during pathological angiogenesis promoting uncontrolled 
expansion of blood vessel networks. 
Sprouting angiogenesis occurs in a stepwise fashion (figure 4.). In some tissues, such as brain 
and retina it is initiated by hypoxia. Which up-regulates the expression of genes such as 
VEGF, needed for vessel formation. At the tip of the sprouts are the tip cells responsible for 
vessel guidance (Gerhardt, Golding et al. 2003), the stalk of the sprout consists of cells 
proliferating and forming the vessel lumen in order to support the elongation of the stalk. Tip 
cells extend filipodial protrusions, which guides them towards angiogenic signals. 
Sprouts anastamose and branches with other sprouts to form vascular loops and networks.  
The newly formed tubes are then covered by mural cells, pericytes and SMC, stabilizing the 
vessel. However, vessels not covered by mural cells regress. Finally blood flow is established 
in the new vessels (Carmeliet 2000; Jain 2003; Adams and Alitalo 2007). 
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Figure 4. Different steps of sprouting angiogenesis. a) Blood vessel consisting of EC and pericytes. b) ECM 
is degraded, pericytes detach and EC’s start to migrate. c) Tip cells guide the sprout, EC’s proliferate in stalk. d) 
Tip cells adhere and form a lumen. e) The new tubes are covered by mural cells. Figure adapted from Bergers 
and Benjamin 2003. 
 
 
2.9.2   Vascular lumen formation 
The formation of a hollow vascular lumen is essential and needed for the transport of blood to 
any given tissue. The mechanism to how the vascular lumen is formed has been under intense 
investigation.  
Two different mechanisms for lumen formation have been proposed recently: cord hollowing 
and cell hollowing (Folkman and Haudenschild 1980; Davis and Camarillo 1996; Kamei, 
Saunders et al. 2006).  According to the cell hollowing principle intracellular vacuoles fuse 
together to form the vascular lumen. In vitro studies also showed that the vacuoles formed 
through pinocytosis (Davis and Camarillo 1996). More recent studies have however, 
suggested that cord hollowing is more likely to be the common mechanism for vascular 
lumen formation (Parker, Schmidt et al. 2004; Herbert, Huisken et al. 2009; Strilic, Kucera et 
al. 2009). However, different blood vessels form via a range of different cellular 
mechanisms. It is not completely unexpected, as endothelium is known to display a high 
level of heterogeneity across different tissues (Aird 2012). I expect that other mechanisms 
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of lumen formation will likely be identified as the vasculature of different organs are more 
extensively examined and understood. 
Studies conducted in the past several years have shed light on the molecular mechanism of 
aortic lumen formation (Iruela-Arispe and Davis 2009; Xu and Cleaver 2011; Axnick and 
Lammert 2012). In vitro studies have suggested cell-cell adhesions, the cytoskeleton and 
apical-basal polarity being crucial for lumen formation (Davis and Senger 2005). 
Investigations performed on mice have further strengthened this notion, showing that 
inactivation of cytoskeletal (RASIP1), polarity (beta1 integrin and Par3) and cell-cell 
adhesion (VE-cadherin) proteins cause luminal defects in the dorsal aorta (DA) (Carmeliet, 
Lampugnani et al. 1999; Gory-Faure, Prandini et al. 1999; Zovein, Luque et al. 2010; Xu, 
Sacharidou et al. 2011). 
 
3 LOSS OF TISSUE INTEGRITY AND STRUCTURE-    
CANCER 
Tumors are no longer considered to be a collection of homogenous cancer cells, as they are 
recognized as organs, whose complexity might even exceed that of normal tissue (Hanahan 
and Weinberg 2011). 
Cancer is often described as uncontrolled growth of cells with the ability to spread and 
colonize other parts of the body. Nearly 80 % of tumors arise from organized epithelial 
tissues. Histological analyses have revealed that tumors have a tissue architecture that is less 
organized and structured compared to that of normal tissue. This suggests that loss of 
architecture and structure is part of or a step towards malignant progression (Hansen and 
Bissell 2000). 
The abnormal growth pattern of cancer develops progressively and is a multi-step process.  
As the tumor grows and progressively evolves away from normal towards malignant 
architecture, there are distinct stopping points along the way, normal → hyperplastic → 
dysplastic → neoplastic → metastatic (figure 5.).  
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Figure 5. Different steps of malignant progression. Figure adapted from /www.ndhealthfacts.org/ 
 
 
Hyperplastic tissues deviate only minimally from those of normal tissue, as they only 
contain excessive amounts of cells. 
Dysplastic tissue is more abnormal, the appearance of individual cells is no longer normal.  
Cytological changes include variability in nuclear size and shape, increased mitotic activity. 
Neoplasia is a further degree of abnormality as tumor cells start to invade into underlying 
tissues. 
Cells formed in a primary tumor may seed new tumor colonies at distant sites in the body, a 
process known as metastasis. 
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3.1   THE HALLMARKS OF CANCER 
Douglas Hanahan and Robert Weinberg wrote in the year 2000, a review article proposing six 
biological traits that needs to be acquired for cancer to develop. These were termed The 
Hallmarks of Cancer (Hanahan and Weinberg 2000), six traits that contributes to the 
transformation of normal cells to malignant. The hallmarks are:  
 
• Resisting cell death 
• Sustaining proliferative signaling 
• Evading growth suppressors 
• Activating invasion and metastasis 
• Enabling replicative immortality 
• Inducing angiogenesis 
 
In their updated Hallmarks of cancer: the next generation, the writers proposed two new 
hallmarks: abnormal metabolic pathways and evading the immune system (Hanahan and 
Weinberg 2011). 
Drugs that will target the individual traits (the hallmarks) required for tumor progression have 
been developed and are in clinical trials, in some cases used for treating patients with 
malignant disease. Drugs targeting angiogenesis, VEGF inhibitors such as, Avastin has been 
approved by the FDA for colon and glioblastoma treatment. Or drugs targeting c-met /HGF 
to inhibit invasion and metastasis, Onartuzumab that has entered phase III in clinical trials for 
treatment of Non-small cell Lung carcinoma (NSCLC). 
Larger parts of this thesis has focused on one of these traits; activating invasion and 
metastasis, we have discovered a novel mechanism for which the cancer cell during hypoxic 
conditions deregulates apical basal polarity promoting invasion and metastasis.  
The deregulation of apical-basal polarity during tumor progression has been well studied 
and documented. The following paragraph will give further insight into how deregulation of 
apical –basal polarity contributes to tumor progression. 
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3.2  Loss of apical basal polarity and tumor progression 
A strong correlation between malignancy and loss of epithelial architecture/organization has 
been documented for most cancers which may be due to loss of polarity (Bilder 2004). The 
deregulation of apical-basal polarity is often depicted as a hallmark of cancer although direct 
evidence whether this is a cause or consequence of tumor progression is not yet clear (Lee 
and Vasioukhin 2008; Royer and Lu 2011). A growth suppressive role of cell polarity stems 
from findings in Drosophila where the polarity proteins such as Crumbs, Scribble, Dlg and 
Lgl act as tumor suppressor genes (Bilder 2004). Furthermore, recent work point to the 
existence of a similar role in mammalian cells as loss of expression of either Crumbs/Crb3 or 
Scribble promotes tumor progression in mouse tumor model systems (Karp, Tan et al. 2008; 
Pearson, Perez-Mancera et al. 2011).  
In epithelial stem cells, polarity proteins are also in control of asymmetric cell division, by 
regulating the polarized localization of cell fate determinants and the correct orientation of 
mitotic spindles. As a result, asymmetric cell division has a fundamental role in the control 
of progenitor or stem cell numbers and differentiation (Knoblich 2010). 
This is of interest as a shift from asymmetric division of epithelial stem cells or cancer-
initiating cells to symmetric divisions would result in dedifferentiation and an increase in 
cancer-initiating cells. Therefore, a defect in asymmetric division could contribute to tumor 
progression. In epithelial stem cells asymmetrical cell division is crucial for the maintenance 
of epithelial tissue homeostasis. When a stem cell divides asymmetrically it gives rise to two 
daughter cells, one with a identical cell fate, the other with a different one (Lee and 
Vasioukhin 2008; Knoblich 2010). Studies performed in Drosophila have indeed confirmed 
that asymmetric division functions as a mechanism of tumor suppression (Januschke and 
Gonzalez 2008).  
Loss of apical-basal polarity also affects cell-cell contacts and has been associated with 
epithelial to mesenchymal transition, EMT. It has been shown that depletion of Par3 disrupts 
tight junction formation (Chen and Macara 2005). Moreover, siRNA experiments showing 
that PATJ is needed for proper polarization and tight junction formation in epithelial cells 
(Shin, Straight et al. 2005). Core polarity proteins are important for the maintenance and the 
formation of the apical junctional complex, it has been proposed that loss of polarity would 
induce or contribute to EMT.  TGF-β stimulation has been shown to down-regulate Par3 
expression through miR-491-5p in rat epithelial cells, suggesting that TGF-β may induce 
disruption of cell polarity (Zhou, Fan et al. 2010).  
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Loss of Par3 in mammary tumor models has been shown to promote invasion and metastasis 
through an aPKC-dependent activation of Jak/Stat3 signaling (McCaffrey, Montalbano et 
al. 2012). Mutushwamy and co-workers also found that loss of Par3 in breast cancer 
promotes invasion and metastasis, the increased invasive potential was due to reduced 
adhesive activity of E-cadherin mediated through constitutive expression of Rac GTPases 
(Xue, Krishnamurthy et al. 2013). 
 
 
3.3   EPITHELIAL TO MESENCHYMAL TRANSITION 
EMT was first discovered as a feature of embryogenesis (Kong, Li et al. 2011). EMT and 
mesenchymal to epithelial transition (MET), its reverse process, are crucial for the formation 
of several organs and tissues in the developing embryo and during numerous embryonic 
events such as gastrulation, neural crest formation and heart valve formation (Thiery, 
Acloque et al. 2009). 
Upon initiation of EMT cellular junctions are deconstructed and junctional proteins are re-
localized or degraded. E-cadherin is cleaved at the plasma membrane and degraded (Yilmaz 
and Christofori 2009).  The loss of epithelial junctions during EMT results in the loss of 
apical-basal polarity (Huang, Guilford et al. 2012). After EMT is induced the expression of 
polarity proteins such as Crb3 and LGL2 is also repressed (Moreno-Bueno, Portillo et al. 
2008). 
During EMT cells reorganize their cortical actin cytoskeleton so that it enables cell 
elongation and directional migration (Thiery and Sleeman 2006; Yilmaz and Christofori 
2009; Yilmaz and Christofori 2010). EMT promotes increased cell contractility and actin 
stress fiber formation. Moesin is believed to be responsible for these dynamic changes in 
actin reorganization (Haynes, Srivastava et al. 2011). However, the molecular mechanism 
controlling actin dynamics during EMT remains to be elucidated.  
Transcriptional regulation of EMT includes micro-RNA’s and several transcription factors 
such as Snail, Slug, Twist, Zeb1 and Prrx1. Signaling pathways such as transforming growth 
factor beta (TGF-β) can induce EMT through induction of for example Zeb1 expression 
(Gregory, Bert et al. 2008). 
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Throughout cancer progression it is believed that epithelial cells undergo a mesenchymal 
transition, during which they lose apical-basal polarity, intercellular adhesions. During 
epithelial to mesenchymal transition (EMT) cells reorganize their cytoskeleton, undergo a 
change in the signaling program that define cell shape and reprogram gene expression, this 
increases the motility of individual cells and enables the development of an invasive 
phenotype (Thiery and Sleeman 2006). Cells express a set of mesenchymal specific genes 
such as N-cadherin and Vimentin and become highly migratory (Yang and Weinberg 2008; 
Scheel and Weinberg 2012). Mesenchymal type of cells lack apical-basal polarity, have a 
spindle shaped morphology and interact with each other through focal points (Thiery and 
Sleeman 2006). 
Mesenchymal like tumor cells penetrate through the basement membrane and enter the 
lymphatic system or the bloodstream, through which they rapidly disseminate to ectopic sites 
in the body. The cells extravasate and colonize surrounding tissue to form metastases. 
Some studies have implicated EMT with the generation of cancer stem cells or tumor 
initiating cells (TIC’s) (Mani, Guo et al. 2008). The TIC’s are considered to be responsible 
for the outgrowth of metastasis and are very resistant to chemotherapy. Slug has been shown 
to induce a TIC phenotype (Guo, Keckesova et al. 2012). Breast cancer TIC’s has been 
shown to express miR-200, which promotes stem cells features (Shimono, Zabala et al. 
2009).  
 
3.4   ECM REMODELING AND CANCER PROGRESSION 
The extracellular matrix is essential for establishment and the maintenance of tissue polarity 
and architecture. The β1- integrin has for example been shown to be crucial for maintaining 
tissue polarity in the mammary gland (Akhtar, Marlow et al. 2009). However, abnormalities 
in ECM dynamics can affect the integrity of the basement membrane as a physical barrier and 
promote EMT, which together facilitates tissue invasion (Song, Jackson et al. 2000; Duong 
and Erickson 2004; Radisky and Radisky 2010). 
The remodeling of the ECM during development is tightly regulated by expression or 
activities of multiple ECM enzymes. The remodeling enzymes are regulated at 
transcriptional, translational and posttranslational levels through inhibiting prodomains and 
selective protease inhibitors (Page-McCaw, Ewald et al. 2007; Aitken and Bagli 2009). The 
activities of the ECM remodeling enzymes are deregulated with age and under disease 
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conditions. In disease, the dynamics of the ECM may become abnormal leading to 
disorganization and changes in essential ECM properties. The main contributors to the altered 
activities of the ECM enzymes are the stromal cells, including cancer-associated fibroblasts 
(CAFs) and immune cells (Bhowmick, Neilson et al. 2004; Orimo, Gupta et al. 2005). But 
also other cell types such as epithelial cells and mesenchymal stem cells may also be involved 
in late stages of tumor progression (Quante, Tu et al. 2011; Singer and Caplan 2011). 
Abnormal ECM dynamics are part of the Hallmarks of cancer (Hanahan and Weinberg 2000; 
Hanahan and Weinberg 2011). Excess ECM production or reduced ECM turnover is essential 
in tissue fibrosis of many organs (Frantz, Stewart et al. 2010). For example, various collagens 
show increased deposition during tumor formation (Zhu, Risteli et al. 1995; Kauppila, 
Stenback et al. 1998).  
Changes in ECM topography may promote cancer cell invasion. The thickening and 
linearization of collagen fibers are found in tumors, in areas where tissue invasion and tumor 
vasculature are observed (Condeelis and Segall 2003; Provenzano, Eliceiri et al. 2006; 
Levental, Yu et al. 2009), suggesting that they play a role in cancer cell invasion. Live 
imaging studies have indeed shown that cancer cells migrate rapidly on collagen fibers in 
areas enriched in collagen (Wang, Wyckoff et al. 2002; Condeelis and Segall 2003; Wyckoff, 
Wang et al. 2007).  
Moreover other ECM components and their receptors such as heparan sulfate proteoglycans 
and CD44 that promote growth factor signaling are often overproduced in cancer (Kainz, 
Kohlberger et al. 1995; Stauder, Eisterer et al. 1995). Thus abnormal changes in the amount 
of the ECM can potentiate oncogenic effects and promote malignant transformation. 
An abnormal ECM can also promote crucial steps during tumor progression. Increase in 
collagen deposition or ECM stiffness, up-regulates integrin signaling and can promote cell 
survival and proliferation (Wozniak, Desai et al. 2003; Paszek, Zahir et al. 2005). Increased 
collagen cross-linking and ECM stiffness promotes focal adhesion assembly, activation of 
ERK and PI3K signaling, contributing to oncogenic transformation (Levental, Yu et al. 
2009). 
In conclusion, the deregulation of ECM dynamics disrupts tissue polarity and promotes cell 
invasion. Cells are directly affected by deregulated ECM dynamics contributing to 
transformation and metastasis. Part of this deregulation of ECM components can be attributed 
to hypoxia induced lysyl oxidase (LOX) (Erler, Bennewith et al. 2006; Barker, Chang et al. 
2011). Excessive expression of LOX results in cross-linking of collagen fibers and other 
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ECM components, it also increases ECM stiffness and promotes metastasis and cancer 
progression (Levental, Yu et al. 2009). 
 
3.5   HYPOXIA 
Oxygen is required and essential for the growth and development of multicellular organisms. 
Aerobic organisms are in need of oxygen to produce energy, therefore oxygen deprivation 
creates stress in living cells.  During low conditions of oxygen, hypoxia, cells activate a 
number of adaptive responses to match oxygen supply with redox, bioenergetic and 
metabolic demands.  
For cells to adapt rapidly to hypoxic conditions, they must be able to sense changes and 
thereafter respond. The initial response is rapid and involves transcriptional and 
posttranscriptional mechanisms.  During adaptation to low oxygen pressure there is a shift 
towards activation of certain genes regulating cellular functions such as angiogenesis, cell 
survival and metabolism (Harris 2002; Gordan and Simon 2007).  Cells arrest in the cell 
cycle, reduce energy consumption and shift towards anaerobic metabolism and secrete pro- 
angiogenic and survival factors.  
Similar to mammalian tissue, tumors need oxygen to grow. Tumors, however become 
hypoxic due to an imbalance between tumor cell oxygen consumption and vascular supply, 
which is caused by uncontrolled proliferation (Brown and Wilson 2004). This in turn means 
that tumor cells have adapted and are able to grow in hypoxic conditions. 
In tumors hypoxia has been associated with increased malignancy, poor prognosis and 
resistance to radiotherapy and chemotherapy (Semenza 2003; Bertout, Patel et al. 2008; 
Vaupel and Mayer 2014). Hypoxia can also cause loss of specialized function, tumor cells de-
differentiate and gain a stem-cell like phenotype as reported in neuroblastoma and breast 
cancer (Jogi, Ora et al. 2002; Helczynska, Kronblad et al. 2003; Lofstedt, Jogi et al. 2004).  
Low stages of differentiation in these tumor types have been shown to be associated with 
poor prognosis and disseminated disease (Giaccia, Siim et al. 2003; Brown and Wilson 
2004).   
Hypoxia has also been linked with EMT and loss of E-cadherin. HIF has been shown to 
decrease the expression of E-cadherin, the first evidence was shown in ovarian carcinoma, 
where nuclear HIF-1α localization correlated with loss of E-cadherin (Imai, Horiuchi et al. 
2003). The mechanism for this action has been suggested to be by activation of Lysil oxidase-
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2 (LOX 2), which in turn activates Snail, repressing E-cadherin (Peinado, Del Carmen 
Iglesias-de la Cruz et al. 2005).  
A key modulator of transcriptional response upon hypoxic stress is the hypoxia-inducible 
factors (HIF’s). The HIF’s are heterodimeric transcription factors that mediate the primary 
transcriptional response to hypoxic stress in normal and transformed cells.  The HIF’s are 
basic helix-loop-helix proteins that are composed of a α-subunit and a stable β-subunit 
(ARNT) (Kaelin and Ratcliffe 2008). Together these subunits bind hypoxia-responsive 
elements (HRE’s) that contain a conserved RCGTG core sequence. During normal conditions 
the α-subunit is degraded, however during hypoxic stress the α-subunit is stabilized so that 
the HIFα protein level and overall HIF transcriptional activity increases as the cells become 
more hypoxic (Majmundar, Wong et al. 2010). 
The mechanisms for protein stabilization of HIF1-α and HIF-2α are similar. Posttranslational 
modifications carried out by the HIF-specific prolyl hydroxylase-domain proteins (PHD 1, 
2, and 3) are responsible for controlling protein stability of the HIF-α subunits. The prolyl 
hydroxylated HIF-α subunits are recognized by the von-Hippel Lindau (VHL) tumor 
suppressor protein which is part of a multiprotein E3 ubiquitin-ligase that polyubiquitylates 
and targets HIF-α for proteasomal degradation (Metzen and Ratcliffe 2004; Kaelin 2005). 
In mammals there are 3 isoforms of HIFα, HIF-1α and HIF-2α that are structurally similar 
and best characterized. The third isoform HIF-3α exists as a splice variant antagonizing HIF-
1α and HIF-2α in a dominant negative way (Kaelin and Ratcliffe 2008).  
Back in 1995, HIF-1α was first described by Semenza and colleagues (Wang, Jiang et al. 
1995), and was shown to have a central role in mediating oxygen dependent transcriptional 
responses. HIF-2α was identified in 1997 by several independent groups (Ema, Taya et al. 
1997; Flamme, Frohlich et al. 1997; Tian, McKnight et al. 1997). Increased expression of 
both HIF-1α and HIF-2α have been reported in a broad range of cancer cell types and have 
been associated with poor prognosis. Intense research has been focused on renal cell 
carcinomas (RCCs), approximately 90% of which lose the function of VHL (Kaelin 2008). 
The general view is that expression of the HIFα proteins in tumor cells drives tumor growth 
and progression by regulating the expression of crucial target genes. 
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3.6 The AP-1 transcription factor 
The activator protein 1 (AP-1) transcription factor is a dimeric complex that comprises 
members of JUN, FOS, ATF (activating transcription factor) and MAF (musculoaponeurotic 
fibrosarcoma).  The AP-1 complex can form many different combinations of heterodimers or 
homodimers, different combinations determine the genes that are regulated by AP-1 
(Chinenov and Kerppola 2001; Wagner 2001; Vogt 2002). AP-1 is activated and regulates 
gene expression in response to a variety of stimuli such as: growth factors, stress signals, 
cytokines, bacterial or viral infections (Hess, Angel et al. 2004).  
The AP-1 proteins are basic leucine-zipper (bZIP) proteins, they dimerize through a leucine 
zipper motif and contain a basic domain for interaction with the DNA backbone (Wagner 
2001). In mammals the main AP-1 proteins are JUN and FOS. 
Upon activation AP-1 up-regulates genes containing the TPA responsive element (TRE), so 
called because it is strongly induced by the tumor promoter 12-O-tetra- decanoylphorbol-
13-acetate (TPA). The TRE element was first discovered in the promoter and enhancer 
elements of metallothionein I gene and simian virus 40 (SV40) (Angel and Karin 1991). 
FOS and JUN were first discovered as viral oncoproteins v-FOS and v-JUN in the Finkel-
Biskis – Jinkins osteosarcoma virus and avian sarcoma virus 17 (Vogt 2002). Several of the 
AP-1 proteins such as c-FOS, c-JUN and FOSB can transform cells in culture very 
efficiently, all have very potent transactivation domains (Jochum, Passegue et al. 2001). 
When overexpressed in mice, c-Fos causes osteosarcoma formation by transformation of 
chondroblasts and osteoblasts (Wang, Grigoriadis et al. 1991; Grigoriadis, Schellander et al. 
1993). 
AP-1 has also been shown to regulate genes that are required for apical-basal polarity, both 
c-Fos and c-Jun can depolarize epithelial cells and induce an invasive phenotype 
(Reichmann, Schwarz et al. 1992; Fialka, Schwarz et al. 1996). However only c-Fos can 
induce invasion in collagen gels when being overexpressed, indicating a more important 
role during late-stage tumorigenesis than c-Jun (Reichmann, Schwarz et al. 1992). In vivo 
the progression of chemically induced papillomas to invasive squamous-cell carcinomas is 
impaired in c-Fos-deficient mice, further supporting the importance of c-Fos in tumor 
invasion (Saez, Rutberg et al. 1995). Several reports have linked hypoxia to c-Fos, showing 
that hypoxia triggers activation of c-Fos in a calcium dependent manner (Muller, Krauss et 
al. 1997; Premkumar, Adhikary et al. 2000). 
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3.7 The MET tyrosine kinase receptor 
During embryogenesis, cells bud off from forming tissues and migrate outwards to form the 
complex architecture of future organs (Bryant and Mostov 2008). Same process occurs in 
adult animals during wound healing and tissue repair, cells migrate into injury sites in an 
effort to recreate the pre-existing structures (Gurtner, Werner et al. 2008).  Pathological 
processes of tumor invasion strongly resemble normal phases of embryogenesis or 
regeneration in that, similar to the wound edge, cells in the tumor front disrupt cell-contacts 
and infiltrate into the surrounding tissue where they resist cell death and grow before 
further dissemination (Schafer and Werner 2008). One major inducer of invasive growth is 
the hepatocyte growth factor (HGF), which also is the ligand for the MET tyrosine kinase 
receptor (Giordano, Ponzetto et al. 1989; Bottaro, Rubin et al. 1991; Naldini, Weidner et al. 
1991). 
In vitro, HGF has been shown to induce tubulogenesis in polarized epithelial cells 
(Montesano, Matsumoto et al. 1991; Montesano, Schaller et al. 1991). In addition HGF 
induced morphogenesis has been shown to act without the disruption of tight junctions in 
Madine Darby –canine kidney epithelial cells (Pollack, Apodaca et al. 2004). A part of the 
polarity machinery, Scrib has also been shown to play an essential role for HGF mediated 
morphogenesis. Depletion of Scrib in epithelial cells blocks HGF mediated extensions and 
morphogenesis (Eastburn, Zegers et al. 2012). 
MET is required for various morphogenetic events in both embryonic and adult life 
(Birchmeier and Gherardi 1998; Birchmeier, Birchmeier et al. 2003) and is believed to 
drive tumor progression (Trusolino and Comoglio 2002; Lai, Abella et al. 2009).  
Downstream signaling of the MET receptor are stereotypical modules that are shared 
among different tyrosine kinase receptors such as: The MAPK cascades (Johnson and 
Lapadat 2002), PI3K-Akt pathway (Ponzetto, Bardelli et al. 1994) and The STAT pathway 
(Boccaccio, Ando et al. 1998), all of these pathways positively control MET-dependent 
proliferation, survival and migration. 
Upon HGF binding the kinase activity of the MET receptor is activated by receptor 
dimerization and trans-phosphorylation of two catalytic tyrosine residues (Tyr1234 and 
Tyr1235) within the kinase activation loop. Next, phosphorylation of two additional dock- 
ing tyrosines in the carboxy-terminal tail (Tyr1349 and Tyr1356), and when 
phosphorylated, these tyrosines act as a degenerate motif for the recruitment of many signal 
relay molecules (Ponzetto, Bardelli et al. 1994).  
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MET also acts as a substrate for several protein-tyrosine phosphatases (PTPs), including the 
receptor PTPs density-enhanced phosphates 1 (dEP1) and the non- receptor PTPs PTP1b 
(also known as PTPN1) (Machide, Hashigasako et al. 2006; Sangwan, Paliouras et al. 
2008). These kind of phosphates oppose MET receptor signaling by triggering 
dephosphorylation of either the catalytic tyrosines (Sangwan, Paliouras et al. 2008) or the 
docking tyrosines (Palka, Park et al. 2003). 
In tumors, MET is induced transcriptionally by hypoxia, inflammatory cytokines or pro-
angiogenic factors (Pennacchietti, Michieli et al. 2003; Bhowmick, Neilson et al. 2004). For 
the effects of MET-dependent invasive growth to be fully executed combined activation of 
multiple pathways is necessary. For example Ras signals are primarily involved in MET-
triggered cell proliferation, whereas PI3K recruitment is required for the induction of cell 
motility and invasion, however, a fully metastatic phenotype can be induced only when 
both effectors are associated with MET (Giordano, Bardelli et al. 1997; Bardelli, Basile et 
al. 1999). 
Interfering with MET signaling appears to be a promising therapeutic approach, currently 
MET kinase inhibitors, HGF inhibitors and antibodies acting as antagonists are in human 
clinical trials. Active immunotherapy against MET expressing tumors have been tested and 
have been approved by the American FDA, for treatment of renal cell carcinoma and 
metastatic melanoma which suffers from deregulated MET activity (Reang, Gupta et al. 
2006). 
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4 THE ANGIOMOTIN PROTEIN FAMILY 
The angiomotin protein family consists of three members (Bratt, Wilson et al. 2002), 
Angiomotin (Amot), Angiomotin-like 1 (AmotL1 or JEAP) and Angiomotin-like 2 
(AmotL2 or MASCOT). Each member of the protein family consists of 2 isoforms that is 
believed to be formed through alternative splicing (Moreau, Lord et al. 2005; Ernkvist, 
Aase et al. 2006; Zheng, Vertuani et al. 2009), however in paper II we show that the p100 
and p60 AmotL2 have different promoter regions. The family members all share common 
structural characteristics. The N-terminal domain is conserved in the full-length protein of 
Amot, AmotL1 and AmotL2 and is composed of glutamine- rich domains, LPxY and PPxY 
motifs (Wang, An et al. 2012; Yi, Shen et al. 2013). All three members interact with 
MAGI1, YAP and E3 ligase NEDD4 through the N-terminal domain (Patrie 2005; Wang, 
Huang et al. 2011; Wang, An et al. 2012). 
The shorter isoforms lack the N-terminal domain, however they are composed of the 
coiled-coiled domain and the c-terminal PDZ binding domain (Troyanovsky, Levchenko et 
al. 2001; Bratt, Wilson et al. 2002).  The coiled-coiled domain serves as an oligomerization 
site, allowing members of the protein family to either form homo-oligomers through self-
association, or hetero-oligomers with other family members (Patrie 2005; Ernkvist, Birot et 
al. 2008; Zheng, Vertuani et al. 2009). 
The Amot protein family has been suggested to play a crucial role in regulating cell 
polarity. The members of the protein family have been shown to associate to Crb3 and Par3 
polarity protein complexes via the c-terminal PDZ domain (Wells, Fawcett et al. 2006; 
Ernkvist, Luna Persson et al. 2009). Binding to Syx, a RhoA GTPase exchange factor is 
also mediated through the c-terminal PDZ domain and is essential for endothelial cell 
migration (Ernkvist, Luna Persson et al. 2009). 
Amot, the founding member of the protein family was first identified in 2001 through a 
yeast-two hybrid screen of a human placenta cDNA library, using the kringle domains 1–4 
of angiostatin as bait (Troyanovsky, Levchenko et al. 2001). It was named Angiomotin, 
meaning motility in latin, due to its migratory effects (Troyanovsky, Levchenko et al. 
2001).   
Amot knock-out mice displayed early lethality, mice died after gastrulation due to 
migration defects (Shimono and Behringer 2003). Further investigations in mice and 
zebrafish indicated that Amot plays a vital role in blood vessel formation, through the 
regulation of endothelial cell migration and polarity (Aase, Ernkvist et al. 2007). Amot has 
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also been reported to bind to the tumor suppressor Merlin via its coiled- coil domain 
resulting in inhibition of Rac and Ras-MAPK pathways. Depletion of Amot in Schwann 
cells prevents cell proliferation and tumorigenesis in vivo, suggesting Amot as a potential 
target for NF2 derived cancers (Yi, Troutman et al. 2011). Targeting of Amot has been 
shown to be a promising approach for inhibition of pathological angiogenesis (Holmgren, 
Ambrosino et al. 2006; Levchenko, Veitonmaki et al. 2008; Arigoni, Barutello et al. 2012).  
AmotL1 was first discovered in a screen for novel tight junction associated proteins, and 
due to similarities to Amot named AmotL1 (Bratt, Wilson et al. 2002; Nishimura, Kakizaki 
et al. 2002). Amot and AmotL1 bind via the N-terminal domain to F-actin, promoting actin 
cytoskeleton remodeling (Ernkvist, Aase et al. 2006; Gagne, Moreau et al. 2009). Although 
Amot and AmotL1 have similar effects on endothelial migration and tight junction 
formation, Amot appears to be essential for the polarity of vascular tip cells whereas 
AmotL1 mainly affects the stability of cell-cell junctions of the stalk cells (Zheng, Vertuani 
et al. 2009). 
The third member of the angiomotin protein family, AmotL2 has been reported to co-
localize with the junctional protein MAGI-1 in epithelial cells, an interaction mediated 
through the N-terminal domain (Patrie 2005). AmotL2 is the only member of the motin 
protein family reported to be responsive to hypoxia, further suggesting a role in stress 
response (Mondon, Mignot et al. 2005; Liu, Laurell et al. 2007).  
AmotL2 has been reported to be an FGF-responsive gene crucial for cell movements in 
zebrafish embryos (Huang, Lu et al. 2007). Recent work suggested that AmotL2 regulates 
postsynaptic differentiation in skeletal muscles by interacting with LL5β, a podosome 
component (Proszynski and Sanes 2013). Furthermore, evidence proposes that AmotL2 and 
other members of the protein family are involved in regulating the HIPPO pathway. Amot 
proteins negatively regulate the HIPPO pathway by associating with YAP1, and thereby 
sequestering it in the cytoplasm (Paramasivam, Sarkeshik et al. 2011; Wang, Huang et al. 
2011; Zhao, Li et al. 2011).   
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5 AIMS OF THIS THESIS 
 
The general aim of this thesis was to characterize the function of 
Angiomotin-like 2 (AmotL2) during blood vessel formation and cancer 
progression. 
 
Specific aims of the papers:  
I. To elucidate the role of AmotL2 in vascular lumen formation. 
II. To investigate the function of hypoxia induced p60 AmotL2 during 
tumor progression. 
III. To asses whether p60 AmotL2 can antagonize the p100 isoform.  
 
 
6  RESULTS AND DISCUSSIONS 
 
Paper I 
The overall aim of this paper was to study if AmotL2 is required for vascular 
development, and to investigate its function at a cellular level. To do so we used two in 
vivo models, zebrafish, conditional knock out mice and in vitro studies using 
endothelial cells. 
In zebrafish the genome has been duplicated throughout evolution, so there are two 
amotl2 genes, amotl2a and amotl2b. In order to determine if amotl2 is involved in 
vascular development we started off by individually targeting amotl2a and amotl2b 
functions in zebrafish using paralogue-specific morpholinos. We used double transgenic 
embryos where erythrocytes express dsRed (Tg(ga- ta1:dsRed)sd2) and the vascular 
endothelial network is visualized via EGFP (Tg(kdrl:EGFP). As previously reported 
(Huang, Lu et al. 2007) depletion of amotl2a resulted in gastrulation defects, however 
at a lower morpholino concentration embryos went through gastrulation but suffered 
  33 
from pericardial oedema starting at 28h post fertilization (h.p.f.). Depletion of amotl2b 
also resulted in pericardial oedema but did not affect gastrulation. In morphant embryos 
an accumulation of erythrocytes was observed in areas of oedema, thus no circulation 
could be detected. In both the individual amotl2a and amotl2b knockdown embryos, 
and especially in the amotl2 MO (double morphants), constrictions within the dorsal 
aorta (DA) were observed. The pericardial vein (PCV) was however not affected. So to 
rule out that the DA defects were not secondary to the loss of blood circulation, we 
targeted embryos with morpholinos against silent heart /tnnt2. These morphants lack 
heartbeat and vascular flow and did not exhibit any DA luminal defects, thus 
concluding that the DA defects are due to depletion of amotl2.  
We further investigated the effects of amotl2 inactivation in mice using a tamoxifen-
inducible conditional knockout mouse model. Endothelium specific depletion of 
amotL2 resulted in aortic constrictions. Similar to our observations in zebrafish, 
endothelial cells of the aorta in amotL2-mutant mice exhibited a rounded cell shape. 
      So what is causing the DA defects? 
We took a closer look by injecting a fli1a:mCherry containing plasmid into 
Tg(fli1a:EGFP) zebrafish embryos, and found that the aortic endothelial cells had 
flattened out and elongated in the amotl2 morphants. The length to width and the length 
to height ratios had significantly changed. The phenotype could be restored by co-
injection of human AMOTL2 messenger RNA (mRNA). We could further show by 
using transgenic fish expressing Lifeact, that the cell shape changes was due to 
perturbations in cytoskeletal architecture. The in vivo experiments indicated a specific 
defect in the actin filaments anchored in the cellular junctions, whereas junction 
formation and the establishment of apical–basal polarity appeared intact. 
In vitro studies using mammalian endothelial (MS1) cells showed that amotL2 was 
located to areas where actin fibers anchor, in the VE-cadherin-positive endothelial 
junctions. AmotL2 depleted cells did not form actin filaments that connect to the cell–
cell junctions, whereas circumferential actin was maintained. Furthermore, calcium 
depletion studies showed that upon depletion of amotL2 by siRNA, VE-cadherin was 
still present at cell–cell junctions, but its connection to actin fibers were lost. 
We and others have shown that the Amot family of proteins associates to the scaffold 
junctional protein MAGI1 via a WW protein interaction motif (Bratt, Wilson et al. 
2002; Patrie 2005). It has further been reported that MAGI1 associates to VE-cadherin 
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via binding to B-catenin (Dobrosotskaya and James 2000; Sakurai, Fukuhara et al. 
2006). So to further investigate if amotL2 functions together with VE-cadherin in 
controlling cytoskeletal architecture we performed co-immunoprecipitation studies 
showing that MAGI1 and amotL2 bind VE-cadherin. However, the binding of MAGI1 
to VE-cadherin was lost in amotL2 siRNA-depleted cells, suggesting that amotL2 
couples MAGI1 and actin fibers to the VE-cadherin junctional complex mediating 
mechanical force. This notion was further strengthen by using traction force 
microscopy, measuring tension between pairs of endothelial cells. We could show that 
AmotL2 was essential for the transmission of junctional force between endothelial cells 
in vitro. In vivo, blebbistatin treatment, targeting contractile actin fibers, between 18–
20h.p.f. caused loss of circulation and reduced length to width and length to height 
ratios mimicking the effects of amotl2 MO in zebrafish. 
In summary we have identified a novel mechanism for aortic lumen expansion by which 
force can be transmitted across cells via adherent junctions and actin fibers. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                       Figure 6. Schematic figure illustrating findings from paper I. 
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Paper II 
The aim of this paper was to investigate the role of hypoxia induced AmotL2 during tumor 
progression. 
The hypoxic regulation of AmotL2 prompted us to analyze the expression pattern of 
AmotL2 in human cancers. Paraffin-embedded sections from colon and breast cancer 
patients were stained for AmotL2. Normal breast epithelia was negative for AmotL2, 
however, the depolarized DCIS (ductal carcinoma in situ) showed strong positivity. Also 
tumor cells that had infiltrated the surrounding stroma were AmotL2 positive. Similar to 
breast tissues, AmotL2 staining was negative in normal colon epithelia. Polarized villous 
structures in the center of the tumors were AmotL2 negative, whereas the budding cells 
located in the tumor front were AmotL2 positive. The staining pattern suggested that 
AmotL2 was localized at large intracellular vesicles. Approximately 65 % of breast and 
colon (Dukes B-C) tumors were positive for AmotL2 staining.  Furthermore, Kaplan-Meier 
analysis of AmotL2 expression and patient survival data showed that AmotL2 expression 
correlates with poor prognosis in colon cancer. AmotL2 encodes for two isoforms with a 
molecular mass of 100 kDa and 60 kDa. Both breast and colon tumor tissues showed 
negative staining when using a p100 AmotL2 specific antibody, indicating a correlation 
between p60 AmotL2 vesicles and malignancy. 
We further went on to analyze if AmotL2 positive staining would overlap with hypoxia 
markers carbonic anhydrase IX (CAIX) or the glucose transporter 1 (Glut1). 
Immunofluorescent staining of cryosections from colon cancer patients showed a clear 
overlap between AmotL2 and CA9, and Glut1.  We further showed in vitro that hypoxia 
would induce p60 AmotL2 in HeLa cells, giving rise to intracellular large vesicles. In vitro 
studies also indicated that hypoxic regulation of p60 AmotL2 is mediated by c-Fos binding 
to the p60 AMOTL2 promoter. c-Fos is an oncogene that is part of AP-1 transcriptional 
complex. The AP1 complex has mainly been shown to be involved in proliferation, cell 
death and cellular transformation. 
Mass spectrometry data helped us identify the large vesicular structures formed when p60 
AmotL2 was expressed. Transport protein particle II complex (TRAPPII) were among the 
proteins that associated to the AmotL2 PDZ-binding motif, this complex associated 
specifically to p60 AmotL2 after 8  h of hypoxia. The TRAPPII is a highly conserved 
tethering complex that binds to Golgi-derived (coat protein complex 1-coated) vesicles to 
mediate Golgi traffic and has been implicated in the selective transport of proteins to the 
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plasma membrane in polarized cells (Qi, Kaneda et al. 2011; Westlake, Baye et al. 2011). 
Components of the TRAPP complex, TRAPPC9 and TRAPPC10 colocalized with p60 
AmotL2 but not with junctional p100 AmotL2. 
Previous work from our lab and others had shown that the Amot protein family interacts 
with PATJ/ Pals1/ Lin7 apical polarity protein complex (Wells, Fawcett et al. 2006; 
Sugihara-Mizuno, Adachi et al. 2007; Ernkvist, Luna Persson et al. 2009). This interaction is 
mediated by binding to the PDZ-binding motif of AmotL2. The PATJ/ Pals1/ Lin7 complex 
is characteristically associated to the apical membrane protein Crb3. Cytoplasmic domain 
of Crb3 could be immunoprecipitated with AmotL2, and endogenous levels of Crb3 
colocalized with p60 AmotL2 in vesicles. Mass spectrometry analysis together with yeast 
two-hybrid screening revealed that also Par3 was directly associated with the PDZ-binding 
motif of AmotL2. Activation of p60 AmotL2 resulted in redistribution of Crb3 and Par3 
from the apical membrane to intracellular vesicles. However, deletion of the PDZ-binding 
motif by which Par3 and Crb3 interact with p60 AmotL2 did not affect the subcellular 
localization of these proteins. Depletion of endogenous levels of p60 AmotL2 in 66c14 cells 
resulted in re-localization of Par3 and Crb3 to apical junctions and cilia. Sequestration of 
Par3 into intracellular vesicles resulted in altered Par3 dynamics, delayed tight junction 
formation, and delayed transport of E-cadherin to cell junctions. 
We further went on to asses if sequestration of Par3 and Crb3 into intracellular vesicles 
would affect apical-basal polarity. MDCK as well as Caco-2 cells forms polarized cysts 
when grown in 3D matrices consisting of matrigel or collagen. Induction of p60 AmotL2, 
but not p100 AmotL2 or p60 AmotL2 ΔILI mutant, inhibited lumen formation and resulted 
in loss of apical–basal polarity. This affect was reversible. AmotL2 expression also 
correlated with loss of polarity in vivo in colon cancer patients.  
Expression of p60 AmotL2 also caused scrambling of apical and basal membrane markers, 
interestingly also scrambling of c-Met from lateral junctions to apical and basolateral 
compartments. The hepatocyte growth factor (HGF) signaling via its receptor, c-Met, is 
closely associated to tumor invasion and metastasis (Boccaccio and Comoglio 2006). To 
further study if p60 AmotL2 would promote invasion, dox-regulated p60 cells were 
embedded in matrigel. p60 expression was not sufficient to induce invasion, however 
addition of HGF to p60 AmotL2-depolarized cells induced a robust invasive response in 
both MDCK and Caco-2 cysts. Depletion of p60 AmotL2 in the metastatic cell line 66c14 
abrogated its invasive phenotype. Stimulation of the 66c14 cells with HGF increased 
invasion of the control cells, whereas AmotL2-depleted cells remained unresponsive. 
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To investigate if AmotL2 would induce invasion in vivo, control or p60 AmotL2 expressing 
Caco-2 cells were injected into mice. Histological analysis showed that control tumors grew 
as polarized glandular epithelia, whereas these structures were completely lost in p60 
AmotL2 expressing tumors. The p60 AmotL2 expressing tumors had infiltrated into the 
surrounding stroma. By silencing endogenous levels of AmotL2 in 66c14 cells we inhibited 
dissemination and tumor growth in vivo. 
In summary we present a novel molecular mechanism how cells from the invasive front of 
metastatic tumors respond to stress signals causing scrambling of polarity complexes. We 
have identified a novel pathway promoting plasticity independent of epithelial-
mesenchymal transition. 
Figure 7. Schematic figure illustrating the findings in paper II. 
 
Paper III 
The aim of this paper was to investigate if p60 AmotL2 can antagonize the full-length 
isoform of AmotL2 and affect the connection of radial actin fibers to E-cadherin. 
We have reported in Paper I that AmotL2 acts as a linker connecting radial fibers to VE-
cadherin in the endothelium. Ongoing work in the group has shown that AmotL2 associates 
 38 
to E-cadherin in the epithelium. We have shown that depletion of full length AmotL2 affects 
packing of the epithelial-cell layer and three-dimensional morphogenesis (Hildebrand et al 
submitted). 
As previously reported the members of the Amot protein family form oligomers via the 
association of the coiled-coil domains (Ernkvist, Birot et al. 2008; Moleirinho, Guerrant et al. 
2014). Different isoforms of AmotL2 have distinct promoters whereupon p100 AmotL2 is 
constitutively expressed, whereas p60 AmotL2 is induced by hypoxia (as shown in paper II).  
In order to test if p60 could associate to p100 AmotL2 and interfere with its normal function, 
we performed immunoprecipitation and immunofluroscent studies using antibodies directed 
against the p100 AmotL2 specific N-terminal domain. We could conclude that p60 and p100 
AmotL2 forms oligomers, resulting in delocalization of p100 AmotL2 to intracellular 
vesicles.  
We further investigated whether relocalization of p100 Amotl2 upon p60 activation would 
affect binding partners. Co-immunoprecipitation studies showed that the association of p100 
AmotL2 to its binding partners was lost in the presence of p60 AmotL2.  The disassociation 
of MAGI1 from AmotL2 resulted in perturbed cytoskeletal architecture. Phalloidine 
visualization revealed a specific loss of radial actin fibers, similar to what we have previously 
observed in p100 depleted cells (Hildebrand et al unpublished data).  
Furthermore, the activation of p60 disassociated p100 AmotL2 from E-cadherin affecting 
epithelial organization and cell-cell cohesions. Live-cell imaging studies revealed that p60 
AmotL2 expressing cells showed increase in filopodial extensions in a confluent epithelial 
layer, which could be due to decreased cohesiveness. Suggesting that p60 affects E-cadherin 
based tension from the adherent junctions.  
In conclusion, we present data showing that p60 AmotL2 promotes invasion in two ways, 
inhibition of apical-basal polarity (paper II) and destabilization of E-cadherin mediated 
adhesions. In paper II we show that p60 AmotL2 activation results in delocalization of E-
cadherin from lateral junctions to apical and basal compartments and delayed junction 
formation. In this paper we extend our findings showing that not only does p60 affect E-
cadherin localization, but also its connection to actin filaments. The effect on the actin 
filaments phenocopy depletion of p100 AmotL2 indicating that p60 AmotL2 may act as a 
p100 AmotL2 antagonist. 
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7  CONCLUDING REMARKS 
In this thesis I have studied the role of AmotL2 in vascular development and cancer 
progression.  When I started this work it was not much known about AmotL2, most efforts 
had been focused on Amot or AmotL1. 
This thesis provides evidence showing that AmotL2 is essential for vascular lumen 
expansion, by transmission of junctional force between cells. We report a novel mechanism 
for which transmission of mechanical force is essential for the coordination of cellular 
morphogenesis. Future studies may show if this mechanism is important for lumen 
formation in other tubular epithelia and ductal organs. 
 This thesis also provides evidence showing that AmotL2 plays a very critical role in 
deregulating apical basal polarity in invasive tumor cells. Here we identified hypoxia-induced 
p60 AmotL2 as a negative regulator of cell polarity during tumor progression. Furthermore 
we provide data showing that p60 AmotL2 affects E-cadherin based tension, promoting cell 
plasticity. We believe that we have discovered a novel pathway that contributes to metastatic 
spread, independent of EMT, and hope that this could add more insight to how cells are 
driven towards a more metastatic phenotype. 
I hope with data presented in paper II, that p60 AmotL2 can be considered as a prognostic 
marker for metastatic disease due to its expression pattern. In paper II we also demonstrate 
that depletion of p60 AmotL2 inhibits tumor growth and invasion, which suggests for p60 
AmotL2 to be a good target for metastatic disease. Recent publications demonstrating the 
importance of cell polarity during tumor progression suggests that perhaps deregulation of 
polarity can be added to the list of hallmarks in the future. 
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and great scientific and non-scientific discussions, what about some Japanese whiskey? 
Braslav, I still have not met anyone as entertaining and as smart as you, you rock! Claire, 
you are the most kind and caring person I know. Sophia, you are like a little sister to me. You 
have become one of my closest friends at work and I will truly miss you a lot. I would also 
like to thank you for all the help with the figures and the cover for this thesis, you have done 
a fantastic job! Good luck with your scientific and artistic career .  Xian lee a cool dude 
reaching a nature paper soon. Mathilde highly appreciate your French humor, viva la France 
. 
Past and present members of the PINK GROUP, Bertrand, for choosing me to help out with 
the CCK Friday seminars. Really enjoyed collaborating with you and hope that we can do so 
in the future. I also appreciate all your input. Miguel and Edel, fantastic people we still miss 
you guys here. Pinolopi, fun seeing you back at CCK, you light up the corridors. Johanna 
probably the kindest and warmest person in CCK. J Fullgrabe, for sharing about your life as 
a parent. Xian lee, great gentleman. 
Thanks to the Östman group, especially Arne, coolest Professor around. Martin and Jeroen 
(the president of the GC) always nice talking to you. Elin did you break the chair? 
New and old members of the Grandér group, in particular; Dan for showing me that you can 
train hard at the gym and become a prefect at the same time. Katja you are just amazing. Per 
for the CHIP data. Matheus, a very active man. Keep going dude!  Iryna fantastic 
personality. Elin always a happy face . Lotte for help with reagents or antibodies. 
Past and present people on the 3rd floor; Johan Hartman, excellent and a very driven 
collaborator, Marja, for all the help with the patient material and stainings. Karthik, Lisa, 
Ran MA, My, Rainer, Markus, Masako, Lina, Mimmi Shoshan the kindest and warmest 
group leader, Mikael, Janna, Helene, Sara Mijwel, Carolina, Linda, Jason, Guiseppe 
(chicco), Aris great talks, Stefano, Sara, Alessandro. 
 
Also thanks to friends and colleagues at the 4th floor: 
Hanif, stop being depressed man and go more often to the gym, you need it ;). Christos 
always fun talking with you, energetic. Cinzia, I really miss the old parties with the gang. 
Klas, the king of the 4th floor. Elisabeth, Fredrik, Dudi, Emarn, Sylvia, Lidi, Chiang, 
Vladimir, Marianne, Susanne, Ahmed, Pinar, Omid train harder at the gym  and 
Andrii, hope we can do research and drink Ukrainian vodka very soon. 
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People from other floors at CCK: 
Barry ¨THE BEAST¨ need I say any more? CCK will never more be the same since you left, 
I hope our paths will cross once more. Dali Zong, miss those gentleman club meetings. 
Walid you are a great friend, stay the same and never change. Alvaro when are we getting 
invited to Chile? Erik do your magic in the big apple, see you maybe soon. Mao you rock the 
dance floor. Berta, Jelena, Anna, Cicci D, Difaf, Hogir, Ghazal, Martin, Mohammad, 
Amir, Padraig, Paola, Angelo, Stig, Xiao Nan, Kaveh, Dimitry. 
 
Some good friends from outside the lab: 
Afshin ¨AMO A¨ my gym buddy and very good friend. I’m very proud of you and know that 
you will make a very good teacher some day soon. I’m very happy that I have you as a friend 
and hope that we can stay in touch wherever in the world we might be. Let’s keep up the 
training routines in the gym until we get 100. Johan L ¨TOSSE¨ you are also a very good 
friend of mine. I am very happy to have met you and gotten much closer to you since the 
London trip. Hope that we can keep our friendship throughout life. Very sad that you will 
miss the dissertation party but we will have an additional party soon . Remember the 3 W’s 
my friend. Lara I am very happy that Johan has you in his life. You brought calm, kindness 
and good, both to his and our lives. Thank you! Johan ¨eken¨ EKLUND keep on training 
DRAGO, you’ll be as strong as me some day soon. KREATIN LADDAD? Also BIG 
congratulations to both you and Tzu for your little daughter. Larsson airgames is fun let me 
know if I can help any more, boat trip soon? Eduardo love hanging out with you man, Krille 
and Petra thanks for great times in Stockholm and Helsingborg. Hans R ¨PLAYER¨ such a 
character, you still look the same since high school. Anna V you will always be my favorite 
ginger ;). Marcus W keep on being HOOD! Babu you are the party wherever you go, keep 
on rockin! Broder Daniel and Farhad take your shades off! 
Salah man I still miss you here in Sweden, you are one of my closest and dearest friends. It 
feels totally weird working here without you going around annoying people showing your 
underwear . I’m very happy I got to know you, during my time here, even though we first 
met in the men’s restroom and you were puking, nevertheless I have always seen you as a big 
brother and a inspiration. Keep up the good work in Stanford! Chia how can someone NOT 
like you? You are a great and a very close friend of mine. Your kindness and big heart is 
appreciated by everyone in your close circle. You are amazing! Keep on being Bruce Wayne 
my friend. Diana aka MY LOÖÖVE, why did you leave Sweden ?  Salah is very lucky 
having you in his life and so are the rest of us. Chiara only you can make wonderful Italian 
food and sweets. Miss your great company in CCK and Sweden. Jeremy ¨FRIES¨ miss you 
my dear friend, who can ever forget that night ¨people¨ broke your chair. Those were the 
days! Will be great seeing you at the party again, hope for no broken chairs though . Ruby, 
miss popular, will never forget those crazy parties at your place.  It was great to experience a 
part of the ¨Ruby¨ era at CCK. Miss you Ruby! Safa aka Hollywood, Ron J, Mr Classy, kärt 
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barn har många namn keep on staying cool bro! Parastou you are just great, fantastic person 
. Jasmine and Björn my favorite thai-swedish couple. 
External collaborators: 
Tomas Weide, Jean Paul-Borg, Nathalie Mazure, Claes Lenander, Per Uhlen, Shigeaki 
Katani 
People that made life easier at CCK, especially: Sören, Eva –Lena, Juan, Erika, Ann Gitt, 
Elle, and Elisabeth 
My family in Iran, my aunts Maryam and Iran thanks for all the great support. Leila, 
Vahideh, Amin, Zari, Mehdi, Kiarash, Mona thank you for all the love. My uncle Latif 
for encouragement and support.  
Min fästmös familj, min svägerska Jennifer och hennes fästman Jocke, samt min 
svägerska Dat-Kin. Svåger Liong och Dat-Hua och mina svärföräldrar Muckieu och Venh 
Phuong ni är en underbar familj, tack för att ni har tagit in mig och är så snälla. Samt faster 
Jenny och Melissa, Vanessa och farbror. 
Masoum, Jaffar ,Kia och Kourosh tack för all stöd genom alla åren, jag uppskattar all hjälp 
och uppmuntran. 
Shahnaz, Amir, Shahin, Salma, Shadi, Said, Shabnam, Hamid tack så jättemkt för all 
stöd. Kvällarna i Knivsta var alltid väldigt roliga och uppskattade. 
Min faster Feresteh och kusiner Gilda och Farivar tack för allt! 
Mormor tack för allt du har lärt mig genom åren. Utan din stöd och uppmuntran hade jag 
aldrig varit där jag är idag. 
Syster, Salome min beskyddande storasyster. Tack för att du alltid funnits där, lyssnat och 
hjälpt till så gott du kunnat. Kunde inte ha önskat mig en bätttre syster, tack för att du finns. 
Ihab det har varit jättekul att umgås och lära känna dig. Du är en rolig och lättsam person 
som har en skön syn på livet. CHIKARMIKONIIIIIII   
Mamma och Pappa tack för ALLT ! Utan er hade jag aldrig någonsin kunnat komma så 
långt som jag gjort idag. Ni har gjort detta och mkt mer möjligt för mig, och varit mina 
stöttepelare genom hela vägen. Ni har uppmuntrat mig och lärt mig att man inte ska begränsa 
sig, och så har ni alltid trott på mig. TACK! Jag älskar er från djupet av mitt hjärta. 
My dear Jessica, you are the missing puzzle piece that was missing in my life, now I’m 
complete! With you I’m happy, but also excited and blessed. I want to thank you for all your 
support and patience, especially during these last months. I look forward to getting married to 
you and later on moving to the US and to start a new chapter. Älskar dig min GHOCHALI! 
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